Switch From Nevolat To Wegovy UK - Cheapest Price £69.00

Clinically Proven UK Registered Pharmacy

Cheapest Switch From Nevolat To Wegovy - Save £20

Switch to Wegovy at the cheapest UK price from £69.00 with £20 off first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

How to Switch From Nevolat to Wegovy Safely in the UK

Many patients ask about how to switch from Nevolat to Wegovy when considering alternative GLP-1 weight loss treatments in the UK. While Nevolat (tirzepatide) and Wegovy (semaglutide) both support clinically significant weight reduction, transitioning between these medications requires careful clinical oversight to maintain efficacy and minimise side effects. This guide provides evidence-based protocols for switching safely under UK prescriber supervision.

Understanding the Switch From Nevolat to Wegovy: Clinical Rationale

The decision to switch from Nevolat to Wegovy typically arises from supply considerations, cost differences, or individual response patterns. Nevolat contains tirzepatide, a dual GIP/GLP-1 receptor agonist, while Wegovy contains semaglutide, a selective GLP-1 receptor agonist. Both medications demonstrated substantial weight reduction in their respective clinical trial programmes—SURPASS trials for tirzepatide showed mean weight loss of 15-22.5% depending on dose, whilst STEP trials for semaglutide reported average reductions of 12.4-14.9% at 68 weeks [1].

When considering this transition, UK prescribers evaluate your current Nevolat dose, duration of treatment, weight loss trajectory, and tolerability profile. The switch protocol differs significantly from starting Wegovy as a treatment-naïve patient, as your body has already adapted to GLP-1 receptor stimulation. This prior exposure often allows for a more streamlined titration schedule compared to first-time users [2].

At Cured Pharmacy, our UK-registered clinical team assesses each switch request individually, ensuring the transition aligns with MHRA-approved prescribing guidelines and your specific clinical circumstances. All switches require completion of our clinical assessment to verify suitability and establish appropriate dosing.

Step-by-Step Protocol to Switch From Nevolat to Wegovy

The recommended protocol for switching from Nevolat to Wegovy depends on your current tirzepatide dose and treatment duration. For patients on Nevolat 2.5mg or 5mg, UK prescribers typically initiate Wegovy at the standard 0.25mg weekly dose, progressing through the established titration schedule (0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg) with 4-week intervals [3].

Patients established on higher Nevolat doses (10mg, 12.5mg, or 15mg) may begin Wegovy at 0.5mg weekly, bypassing the initial 0.25mg step, though this remains at prescriber discretion based on your tolerability history. There is no requirement for a washout period—you simply commence Wegovy on your next scheduled injection day after your final Nevolat dose.

Timing Your Switch From Nevolat to Wegovy

Both medications are administered weekly, making the transition straightforward from a scheduling perspective. If your last Nevolat injection was on a Monday, your first Wegovy dose should be administered the following Monday. This maintains consistent weekly GLP-1 receptor stimulation without overlap or gaps that could affect glycaemic control or appetite regulation.

Some patients experience mild recurrence of appetite or reduced satiety during the first 2-3 weeks after switching, particularly when moving from higher Nevolat doses to initial Wegovy titration doses. This temporary effect typically resolves as you progress through the Wegovy dose escalation schedule [4].

Expected Outcomes When You Switch From Nevolat to Wegovy

Clinical data comparing direct switches between tirzepatide and semaglutide remains limited, but real-world evidence from UK prescribers suggests most patients maintain their weight loss trajectory when transitioning appropriately. In the STEP 1 trial, semaglutide 2.4mg produced mean weight reduction of 14.9% from baseline over 68 weeks in treatment-naïve patients [1].

Patients switching from Nevolat should anticipate continued weight loss, though the rate may differ slightly given the mechanistic differences between dual GIP/GLP-1 agonism and selective GLP-1 agonism. Individual response varies considerably—some patients report enhanced tolerability with semaglutide, whilst others prefer tirzepatide's efficacy profile. Your UK prescriber will monitor your progress through follow-up assessments to optimise outcomes.

At Cured Pharmacy, Wegovy is available from £20 offering significant cost advantages compared to Nevolat for many patients. This pricing includes UK prescriber assessment, genuine MHRA-licensed medication, and discreet next-day delivery across the UK.

Treatment Active Ingredient Frequency Starting Price
Wegovy Semaglutide Weekly injection From £89.00
Mounjaro Tirzepatide Weekly injection From £145.00
Saxenda Liraglutide Daily injection From £68.00
Wegovy Oral Tablets Semaglutide Daily tablet From £83.00

Managing Side Effects During the Switch From Nevolat to Wegovy

The side effect profiles of Nevolat and Wegovy overlap substantially, as both medications modulate GLP-1 receptors. Common adverse effects include nausea, diarrhoea, constipation, and abdominal discomfort, typically most pronounced during dose escalation phases [5]. Patients already established on Nevolat often experience fewer gastrointestinal symptoms when starting Wegovy compared to treatment-naïve individuals, as your digestive system has adapted to GLP-1 agonist effects.

If you experienced specific intolerabilities on Nevolat—such as persistent nausea or injection site reactions—these may improve with semaglutide, though this varies individually. Conversely, some patients find tirzepatide better tolerated. UK prescribers recommend maintaining consistent injection technique, rotating sites weekly (abdomen, thigh, or upper arm), and taking Wegovy on the same day each week to minimise side effects.

When to Contact Your Prescriber After Switching From Nevolat to Wegovy

Seek immediate medical advice if you experience severe abdominal pain (which may indicate pancreatitis), persistent vomiting preventing fluid intake, visual changes, or signs of allergic reaction. These serious adverse events are rare but require prompt clinical evaluation [6].

For less urgent concerns—such as increased nausea compared to your Nevolat experience, injection site issues, or questions about dose progression—contact Cured Pharmacy's clinical team through your patient portal. Our UK-registered pharmacists and prescribers provide ongoing support throughout your treatment journey.

Cost Comparison: Switch From Nevolat to Wegovy for UK Patients

Pricing represents a significant consideration for many patients contemplating the switch from Nevolat to Wegovy. At Cured Pharmacy, Wegovy is available from £69.00 per pen, with transparent pricing displayed before you complete your clinical assessment. New patients receive £20 off their first order using code Weightlossnew, reducing initial costs further.

The Wegovy dosing schedule requires one pen per month during titration phases (0.25mg and 0.5mg doses provide 4 weeks of treatment per pen), progressing to maintenance dosing at 2.4mg weekly. This pricing structure offers competitive value compared to other UK-licensed weight loss injections, whilst maintaining the same rigorous clinical oversight and genuine MHRA-approved medication.

All pricing at Cured Pharmacy includes UK prescriber consultation, medication cost, and next-day delivery. There are no hidden fees or subscription requirements—you simply reorder when needed through your secure patient account.

Starting Your Switch From Nevolat to Wegovy With Cured Pharmacy

To initiate your switch from Nevolat to Wegovy through Cured Pharmacy, complete our online clinical assessment, which takes under 3 minutes. You'll provide details about your current Nevolat dose, treatment duration, weight loss progress, and any side effects experienced. Our UK-registered prescribers review every assessment individually—this is not an automated process.

If approved, your Wegovy prescription is dispensed by our GPhC-registered pharmacy (registration number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). Medication is dispatched in 100% discreet packaging via next-day delivery to any UK address. Your patient portal provides ongoing access to clinical support, reorder functionality, and treatment monitoring tools.

Switching between weight loss medications requires the same clinical rigour as initiating treatment. Our assessment ensures Wegovy remains appropriate for your circumstances, evaluates contraindications, and establishes the safest transition protocol based on your Nevolat history. This patient-centred approach reflects our commitment to safe, effective weight management support across the UK.

What to Expect During Your Switch From Nevolat to Wegovy Assessment

The clinical assessment covers your medical history, current medications, weight loss goals, previous GLP-1 agonist experience, and any adverse effects encountered on Nevolat. Be prepared to provide your current weight, height, and details of any relevant medical conditions such as thyroid disorders, pancreatitis history, or diabetic retinopathy.

UK prescribers may recommend specific monitoring during your switch, such as tracking weight weekly for the first month or maintaining a symptom diary. This individualised approach ensures your transition is optimised for safety and efficacy, with adjustments made based on your response to Wegovy compared to your previous Nevolat treatment [7].

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Aronne, L. J., Sattar, N., Horn, D. B., et al. (2022). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA, 331(1), 38-48. [accessed 15 August 2026]
  3. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  4. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: The STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
  5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  6. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 15 August 2026]
  7. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. [accessed 15 August 2026]
  8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How much is Wegovy 0.25mg?
Wegovy 0.25mg costs from £69.00 at Cured Pharmacy, You just need to have a free online consultation, to check your eligibility.
How much is Wegovy 0.5mg?
Wegovy 0.5mg costs from £89.00 at Cured Pharmacy, You just need to have a free online consultation, to check your eligibility.
Can I switch from Nevolat to Wegovy immediately?
Yes, you can switch from Nevolat to Wegovy on your next scheduled injection day with no washout period required. UK prescriber assessment is mandatory to determine your appropriate starting Wegovy dose based on your current Nevolat dose and treatment history.
Will I regain weight when I switch from Nevolat to Wegovy?
Most patients maintain their weight loss trajectory when switching from Nevolat to Wegovy with appropriate dose titration. Temporary appetite changes may occur during initial weeks but typically resolve as you progress through the Wegovy dosing schedule.
What Wegovy dose should I start on after Nevolat 10mg?
Patients on Nevolat 10mg typically begin Wegovy at 0.5mg weekly, though some UK prescribers may recommend starting at 0.25mg depending on your tolerability history. Your prescriber will determine the safest starting dose during clinical assessment.
Is Wegovy as effective as Nevolat for weight loss?
Clinical trials show both medications produce significant weight reduction—tirzepatide averaged 15-22.5% weight loss in SURPASS trials, whilst semaglutide achieved 12.4-14.9% in STEP trials. Individual response varies, and your UK prescriber can discuss expected outcomes based on your treatment history.
How much does it cost to switch from Nevolat to Wegovy at Cured Pharmacy?
Wegovy is available from £69.00 at Cured Pharmacy, with £20 off your first order using code Weightlossnew. This includes UK prescriber assessment, genuine MHRA-licensed medication, and next-day delivery.
Will side effects be worse when switching from Nevolat to Wegovy?
Patients already established on Nevolat often experience fewer side effects when starting Wegovy compared to treatment-naïve individuals, as your body has adapted to GLP-1 receptor stimulation. Gastrointestinal symptoms are typically milder during the switch.
Do I need a new prescription to switch from Nevolat to Wegovy?
Yes, switching from Nevolat to Wegovy requires a new UK prescription following clinical assessment. Complete Cured Pharmacy's online assessment to have your suitability evaluated by our UK-registered prescribers.
How long does the switch from Nevolat to Wegovy take?
Once your clinical assessment is approved, Wegovy is dispatched via next-day delivery. You begin your first Wegovy injection on your next scheduled injection day after your final Nevolat dose, making the transition immediate from a timing perspective.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.